PI3K/GSKβ/c-Myc is crucial for pancreatic cancer cell cycle progression.187 GSKβ inhibition decreases the expression of NF-κB and NF-κB -mediated expression of c-Myc in pancreatic cancer, thereby reducing tumor growth.188. Here, NFKB1 is linked to neoplasm.